112 related articles for article (PubMed ID: 8774398)
1. Study design of the International Stroke Trial (IST), baseline data, and outcome in 984 randomised patients in the pilot study.
J Neurol Neurosurg Psychiatry; 1996 Apr; 60(4):371-6. PubMed ID: 8774398
[TBL] [Abstract][Full Text] [Related]
2. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group.
Lancet; 1997 May; 349(9065):1569-81. PubMed ID: 9174558
[TBL] [Abstract][Full Text] [Related]
3. Indications for early aspirin use in acute ischemic stroke : A combined analysis of 40 000 randomized patients from the chinese acute stroke trial and the international stroke trial. On behalf of the CAST and IST collaborative groups.
Chen ZM; Sandercock P; Pan HC; Counsell C; Collins R; Liu LS; Xie JX; Warlow C; Peto R
Stroke; 2000 Jun; 31(6):1240-9. PubMed ID: 10835439
[TBL] [Abstract][Full Text] [Related]
4. Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation: a double-blind randomised study. HAEST Study Group. Heparin in Acute Embolic Stroke Trial.
Berge E; Abdelnoor M; Nakstad PH; Sandset PM
Lancet; 2000 Apr; 355(9211):1205-10. PubMed ID: 10770301
[TBL] [Abstract][Full Text] [Related]
5. CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. CAST (Chinese Acute Stroke Trial) Collaborative Group.
Lancet; 1997 Jun; 349(9066):1641-9. PubMed ID: 9186381
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of aspirin, unfractionated heparin, both, or neither during endovascular stroke treatment (MR CLEAN-MED): an open-label, multicentre, randomised controlled trial.
van der Steen W; van de Graaf RA; Chalos V; Lingsma HF; van Doormaal PJ; Coutinho JM; Emmer BJ; de Ridder I; van Zwam W; van der Worp HB; van der Schaaf I; Gons RAR; Yo LSF; Boiten J; van den Wijngaard I; Hofmeijer J; Martens J; Schonewille W; Vos JA; Tuladhar AM; de Laat KF; van Hasselt B; Remmers M; Vos D; Rozeman A; Elgersma O; Uyttenboogaart M; Bokkers RPH; van Tuijl J; Boukrab I; van den Berg R; Beenen LFM; Roosendaal SD; Postma AA; Krietemeijer M; Lycklama G; Meijer FJA; Hammer S; van der Hoorn A; Yoo AJ; Gerrits D; Truijman MTB; Zinkstok S; Koudstaal PJ; Manschot S; Kerkhoff H; Nieboer D; Berkhemer O; Wolff L; van der Sluijs PM; van Voorst H; Tolhuisen M; Roos YBWEM; Majoie CBLM; Staals J; van Oostenbrugge RJ; Jenniskens SFM; van Dijk LC; den Hertog HM; van Es ACGM; van der Lugt A; Dippel DWJ; Roozenbeek B;
Lancet; 2022 Mar; 399(10329):1059-1069. PubMed ID: 35240044
[TBL] [Abstract][Full Text] [Related]
7. Anticoagulants versus antiplatelet agents for acute ischaemic stroke.
Berge E; Sandercock P
Cochrane Database Syst Rev; 2002; (4):CD003242. PubMed ID: 12519590
[TBL] [Abstract][Full Text] [Related]
8. Aspirin and heparin in acute ischaemic stroke in older patients.
Gubitz GJ; Sandercock PA
Drugs Aging; 1999 Jul; 15(1):29-36. PubMed ID: 10459730
[TBL] [Abstract][Full Text] [Related]
9. Clinical effects of anticoagulant therapy in suspected acute myocardial infarction: systematic overview of randomised trials.
Collins R; MacMahon S; Flather M; Baigent C; Remvig L; Mortensen S; Appleby P; Godwin J; Yusuf S; Peto R
BMJ; 1996 Sep; 313(7058):652-9. PubMed ID: 8811758
[TBL] [Abstract][Full Text] [Related]
10. Antithrombotic therapy in acute ischaemic stroke: an overview of the completed randomised trials.
Sandercock PA; van den Belt AG; Lindley RI; Slattery J
J Neurol Neurosurg Psychiatry; 1993 Jan; 56(1):17-25. PubMed ID: 8429318
[TBL] [Abstract][Full Text] [Related]
11. Aspirin or heparin in acute stroke.
Pereira AC; Brown MM
Br Med Bull; 2000; 56(2):413-21. PubMed ID: 11092090
[TBL] [Abstract][Full Text] [Related]
12. Antithrombotic drugs and ischaemic stroke.
Prescrire Int; 2013 Nov; 22(143):270-1. PubMed ID: 24427842
[TBL] [Abstract][Full Text] [Related]
13. [Antithrombotic treatment in acute ischemia stroke].
Díez-Tejedor E; Alonso de Leciñana M; Counsell C; Sandercock P
Neurologia; 1995 Dec; 10 Suppl 2():48-54. PubMed ID: 8714450
[TBL] [Abstract][Full Text] [Related]
14. Ischaemic stroke: acute-phase drug therapy. Mostly aspirin and heparin.
Prescrire Int; 2005 Aug; 14(78):146-52. PubMed ID: 16106599
[TBL] [Abstract][Full Text] [Related]
15. Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke.
Sandercock PA; Counsell C; Tseng MC
Cochrane Database Syst Rev; 2008 Jul; (3):CD000119. PubMed ID: 18646059
[TBL] [Abstract][Full Text] [Related]
16. Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke. Multicentre Acute Stroke Trial--Italy (MAST-I) Group.
Lancet; 1995 Dec; 346(8989):1509-14. PubMed ID: 7491044
[TBL] [Abstract][Full Text] [Related]
17. [Antithrombotic therapy after cerebral ischemia].
Schellinger PD; Orberk E; Hacke W
Fortschr Neurol Psychiatr; 1997 Sep; 65(9):425-34. PubMed ID: 9417427
[TBL] [Abstract][Full Text] [Related]
18. Blood pressure and clinical outcomes in the International Stroke Trial.
Leonardi-Bee J; Bath PM; Phillips SJ; Sandercock PA;
Stroke; 2002 May; 33(5):1315-20. PubMed ID: 11988609
[TBL] [Abstract][Full Text] [Related]
19. Medium intensity oral anticoagulants versus aspirin after cerebral ischaemia of arterial origin (ESPRIT): a randomised controlled trial.
; Halkes PH; van Gijn J; Kappelle LJ; Koudstaal PJ; Algra A
Lancet Neurol; 2007 Feb; 6(2):115-24. PubMed ID: 17239798
[TBL] [Abstract][Full Text] [Related]
20. The experiences of an acute stroke unit--implications for multicentre acute stroke trials.
Morris AD; Grosset DG; Squire IB; Lees KR; Bone I; Reid JL
J Neurol Neurosurg Psychiatry; 1993 Apr; 56(4):352-5. PubMed ID: 8482954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
